Difference between revisions of "Part:BBa K209400"
(→Usage and Biology) |
(→Usage and Biology) |
||
Line 8: | Line 8: | ||
− | ''' | + | '''Characterization by Team UCSF 2010''' |
− | In 2009 we used this synthetic GPCR to mediate chemotaxis towards the ligand, CNO | + | In 2009 we used this synthetic GPCR to mediate chemotaxis towards the ligand, CNO.<br> |
For more information, refer to our wiki here: http://2009.igem.org/Team:UCSF | For more information, refer to our wiki here: http://2009.igem.org/Team:UCSF | ||
+ | In 2010, we showed that this synthetic GPCR increases killer cell activation in the presence of the ligand, CNO:<br> | ||
− | + | <img src="https://static.igem.org/mediawiki/2010/0/0c/GPCR_graph.png" /><br> | |
+ | '''Figure: Enhancing killer cell activation with a synthetic GPCR'''<br> | ||
+ | A synthetic GPCR shown to mediate immune cell migration towards the ligand CNO was introduced to T cells as a potential way to increase the level of kinase activation. IL-2 production was used as a measure of T-cell activation. The results show that in the presence of CNO, T cells transfected with the synthetic GPCR have a higher level of activation than non-transfected T-cells. | ||
+ | <br> | ||
For the complete results, refer to our wiki here: | For the complete results, refer to our wiki here: | ||
http://2010.igem.org/Team:UCSF/Project/Signaling | http://2010.igem.org/Team:UCSF/Project/Signaling | ||
Line 21: | Line 25: | ||
Reference: | Reference: | ||
Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Armbruster BN, Li X, Pausch MH, Herlitze S, Roth BL. Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5163-8. Epub 2007 Mar 2. | Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Armbruster BN, Li X, Pausch MH, Herlitze S, Roth BL. Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5163-8. Epub 2007 Mar 2. | ||
+ | |||
+ | <br> | ||
<!-- --> | <!-- --> |
Latest revision as of 23:08, 26 October 2010
AarI B-C part, hM4D
hM4 DREADD flanked by AarI BC sites.
Usage and Biology
This is an engineered version of the human M4 muscarinic receptor that can be activated by the otherwise inert small molecule, clozapine-N-oxide.
Characterization by Team UCSF 2010
In 2009 we used this synthetic GPCR to mediate chemotaxis towards the ligand, CNO.
For more information, refer to our wiki here: http://2009.igem.org/Team:UCSF
In 2010, we showed that this synthetic GPCR increases killer cell activation in the presence of the ligand, CNO:
<img src="" />
Figure: Enhancing killer cell activation with a synthetic GPCR
A synthetic GPCR shown to mediate immune cell migration towards the ligand CNO was introduced to T cells as a potential way to increase the level of kinase activation. IL-2 production was used as a measure of T-cell activation. The results show that in the presence of CNO, T cells transfected with the synthetic GPCR have a higher level of activation than non-transfected T-cells.
For the complete results, refer to our wiki here:
http://2010.igem.org/Team:UCSF/Project/Signaling
Reference:
Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Armbruster BN, Li X, Pausch MH, Herlitze S, Roth BL. Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5163-8. Epub 2007 Mar 2.
Sequence and Features
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 184
Illegal PstI site found at 979 - 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 1215
Illegal PstI site found at 184
Illegal PstI site found at 979 - 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 184
Illegal PstI site found at 979 - 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 184
Illegal PstI site found at 979
Illegal NgoMIV site found at 1086 - 1000COMPATIBLE WITH RFC[1000]